Pharmascience invites you to meet members of our dedicated team on October 9-11, 2012 at CPhI Worldwide, Stand 5D16 at Feria de Madrid, Spain.
Pharmascience Inc. and Korea Kolmar Holdings, based in Seoul, Korea, today announced they have entered into an agreement to create a new company, Pharmascience Korea, which expects to launch Canadian-made bio-equivalent medicines in the country by 2014.
We are very pleased to announce that earlier today Pharmascience and Bellus concluded the previously announced strategic partnership between the two companies whereby Pharmascience will pay a total of id="mce_marker"7.25 million to Bellus, for a 10.4% ownership stake in Bellus.
Pharmascience Inc has proudly entered into a strategic partnership and financing with Bellus Health ("Bellus"), a public company, whereby Pharmascience will own over 10% of Bellus